Stem Cells Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Stem Cell Market
The stem cell market size was valued at USD 15.07 billion in 2023, and the market is now projected to grow from USD 17.02 billion in 2024 to USD 56.15 billion by 2032, exhibiting a CAGR of 16.1% during the forecast period of 2024-2032.
The COVID-19 pandemic to start with drove demand for stem cellular products in treating the virus, sparking improved medical trials. However, demanding situations and delays in trials caused gradual marketplace increase in 2021. Despite this setback, robust investments and product pipelines are expected to fuel speedy boom with an excessive CAGR forecasted for the approaching years.
The increasing programs of stem cellular products in studies and therapeutics are poised to power sizeable market increase. Their versatility spans regions like regenerative medicinal drug, which objectives restoring normal functions in sufferers with persistent illnesses or excessive injuries. Stem cells, as a promising cellular supply, are garnering attention from researchers, scientists, and clinicians for pioneering treatments throughout numerous ailment classes. This expanded adoption and ongoing innovation are key elements fueling the marketplace's boom trajectory.
The emergence of prompted Pluripotent Stem Cells (iPSCs) as an alternative to Embryonic Stem Cells (ESCs) is poised to significantly power marketplace increase. IPSC era, derived from grownup somatic cells and reprogrammed to pluripotency, avoids the moral issues related to ESCs, which involve embryo destruction. This moral benefit has caused expanded applications in disease modeling, drug discovery, and mobile therapy improvement, fueling the market's momentum and adoption of iPSC-based totally technologies.
Comprehensive Analysis of Stem Cell Market
The stem cell market growth is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the industry. These segmentations are methodically segregated by cell type analysis, by application analysis and by end user analysis. By cell type analysis include, Mesenchymal Stem Cells (MSCs), Embryonic Stem Cells (ESCs), Adult Stem Cells (ASCs), and induced Pluripotent Stem Cells (iPSCs). By application analysis include, research and clinical. By end user analysis include, hospitals, pharmaceutical & biotechnology companies, academic & research institutes, and others.
The North America region lead the stem cell market share by benefitting a market size of USD 8.00 billion in 2023 due to its huge volume of research and development activities, rising approvals for stem cell therapies, and advanced product launches across the region.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, PromoCell GmbH, AcceGen, Bio-Techne, Cellular Engineering Technologies, Merck KgaA, Thermo Fisher Scientific Inc., Lonza, Miltenyi Biotec B.V. & Co. KG, STEMCELL Technologies, these market players provide a level-playing competitive landscape.
In December 2022, GenCure & the University of Texas at San Antonio (UTSA) collaborated to develop cellular therapy products, services,& testing.
Segmentation Table
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 16.1% from 2024-2032
Unit Value (USD Billion)
Segmentation By Cell Type
Embryonic Stem Cells (ESCs)
Mesenchymal Stem Cells (MSCs)
Adult Stem Cells
Induced Pluripotent Stem Cells (iPSCs)
By Application
Research
Clinical
By End-user
Hospitals
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America (By Cell Type, Application, End-user, Country/Sub-Region)
U.S. (By Application)
Canada (By Application)
Europe (By Cell Type, Application, End-user, Country/Sub-Region)
U.K. (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Cell Type, Application, End-user, Country/Sub-Region)
Japan (By Application)
China (By Application)
India (By Application)
Australia (By Application)
South Korea (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Cell Type, Application, End-user, Country/Sub-Region)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
The Middle East & Africa (By Cell Type, Application, End-user, Country/Sub-Region)
South Africa (By Application)
GCC (By Application)
Rest of the Middle East & Africa (By Application)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Overview: Funding Initiatives for Stem Cell Research
- 4.2. Prevalence/Incidence of Relevant Chronic Disorders – By Key Countries/Region
- 4.3. New Product Launches, By Key Players
- 4.4. Pipeline Analysis, By Key Players
- 4.5. Snapshot of Key Start-ups in the Stem Cells Market
- 4.6. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 4.7. Impact of COVID-19 on the Market
- 5. Global Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Cell Type
- 5.1.1. Embryonic Stem Cells (ESCs)
- 5.1.2. Mesenchymal Stem Cells (MSCs)
- 5.1.3. Adult Stem Cells
- 5.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Research
- 5.2.2. Clinical
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals
- 5.3.2. Pharmaceutical and Biotechnology Companies
- 5.3.3. Academic & Research Institutes
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Cell Type
- 6.1.1. Embryonic Stem Cells (ESCs)
- 6.1.2. Mesenchymal Stem Cells (MSCs)
- 6.1.3. Adult Stem Cells
- 6.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Research
- 6.2.2. Clinical
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals
- 6.3.2. Pharmaceutical and Biotechnology Companies
- 6.3.3. Academic & Research Institutes
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 7. Europe Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Cell Type
- 7.1.1. Embryonic Stem Cells (ESCs)
- 7.1.2. Mesenchymal Stem Cells (MSCs)
- 7.1.3. Adult Stem Cells
- 7.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Research
- 7.2.2. Clinical
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals
- 7.3.2. Pharmaceutical and Biotechnology Companies
- 7.3.3. Academic & Research Institutes
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Scandinavia
- 7.4.6.1. By Application
- 7.4.7. Rest of Europe
- 7.4.7.1. By Application
- 8. Asia Pacific Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Cell Type
- 8.1.1. Embryonic Stem Cells (ESCs)
- 8.1.2. Mesenchymal Stem Cells (MSCs)
- 8.1.3. Adult Stem Cells
- 8.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Research
- 8.2.2. Clinical
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals
- 8.3.2. Pharmaceutical and Biotechnology Companies
- 8.3.3. Academic & Research Institutes
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 9. Latin America Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Cell Type
- 9.1.1. Embryonic Stem Cells (ESCs)
- 9.1.2. Mesenchymal Stem Cells (MSCs)
- 9.1.3. Adult Stem Cells
- 9.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Research
- 9.2.2. Clinical
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals
- 9.3.2. Pharmaceutical and Biotechnology Companies
- 9.3.3. Academic & Research Institutes
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 10. Middle East & Africa Stem Cells Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Cell Type
- 10.1.1. Embryonic Stem Cells (ESCs)
- 10.1.2. Mesenchymal Stem Cells (MSCs)
- 10.1.3. Adult Stem Cells
- 10.1.4. Induced Pluripotent Stem Cells (iPSCs)
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Research
- 10.2.2. Clinical
- 10.3. Market Analysis, Insights and Forecast – By End-user
- 10.3.1. Hospitals
- 10.3.2. Pharmaceutical and Biotechnology Companies
- 10.3.3. Academic & Research Institutes
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.4.1. GCC
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. PromoCell GmbH
- 11.2.1.1. Overview
- 11.2.1.2. Cell Type
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. AcceGen
- 11.2.2.1. Overview
- 11.2.2.2. Cell Type
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Bio-Techne
- 11.2.3.1. Overview
- 11.2.3.2. Cell Type
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Cellular Engineering Technologies
- 11.2.4.1. Overview
- 11.2.4.2. Cell Type
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Merck KgaA
- 11.2.5.1. Overview
- 11.2.5.2. Cell Type
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Thermo Fisher Scientific Inc.
- 11.2.6.1. Overview
- 11.2.6.2. Cell Type
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Lonza
- 11.2.7.1. Overview
- 11.2.7.2. Cell Type
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Miltenyi Biotec B.V. & Co. KG
- 11.2.8.1. Overview
- 11.2.8.2. Cell Type
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. STEMCELL Technologies
- 11.2.9.1. Overview
- 11.2.9.2. Cell Type
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook